Lunai Bioworks (LNAI) executive compensation, 2025 proxy

David Weinstein, Chief Executive Officer, was paid $1.2M in 2025.

Filed
October 15, 2025
Annual meeting
October 31, 2025
Pay year
2025
Named executives
5
CEO total pay
$1.2M2025
CEO pay in equity
74%$868,950 in awards
CEO option awards
$731,200Grant-date valuation
CEO stock awards
$137,750Grant-date valuation
Fuentes total compensation
$290,6892025 total
Tarsh total compensation
$220,6252025 total
Binette total compensation
$240,2882025 total
Weinstein target bonus
$150,000Annual maximum

How Weinstein was paid

$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary26%Stock awards12%Option awards62%

Named executive officers

ExecutiveTotal
David WeinsteinChief Executive Officer$1,170,518
Mark Dybul, M.D.Chief Executive Officer$242,107
Nathen FuentesChief Financial Officer$290,689
Simon TarshChief Financial Officer$220,625
Francois Binette PhD.Chief Operating Officer$240,288

What changed and why

  • $1.2M$1,170,518 was CEO David Weinstein’s 2025 total compensation, including $731,200 in option awards.
  • $302K$301,568 was Weinstein’s 2025 salary, while his employment agreement provides a $400,000 annual base salary.
  • $242K$242,107 was former CEO Mark Dybul’s 2025 compensation, including $80,208 accrued paid time off.
  • $291K$290,689 was CFO Nathen Fuentes’s 2025 total compensation, including $151,750 in option awards.
  • 2025 compensation generally consisted of base salary, restricted stock units and option awards.
  • 1-for-10 reverse split adjustments apply to outstanding equity award share and per-share figures.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.